Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Planned sale Head of Development sold 108 shares at $221.49 ($23,921)
  2. 144 Insider Sale of Securities
  3. 4 Open-market buy Director bought 455 shares at $222.54 ($101,256)
  4. 10-K Report Annual Report
  5. 4 Shares withheld for taxes EVP, Human Resources gave up 634 shares (to pay taxes)
  6. 4 Planned sale Head of Development sold 419 shares at $239.45 ($100,330)
  7. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 761 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,431 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Accounting Officer gave up 245 shares (to pay taxes)
  10. 4 Shares withheld for taxes Head of Global Product Strat. gave up 445 shares (to pay taxes)
  11. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 938 shares (to pay taxes)
  12. 8-K Event Results of operations
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 144 Insider Sale of Securities
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 655 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Human Resources gave up 498 shares (to pay taxes)

Page 11 of 137 · 2,721 filings